Scientific article
English

Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk

Published inPharmacological Reports, vol. 61, no. 1, p. 13-21
Publication date2009
Abstract

The endocannabinoid system is a crucial player in the inflammatory processes underlying atherosclerosis. Recently, basic research studies and animal models have strongly supported the role of the endocannabinoid system not only in the regulation of classical cardiovascular risk factors (including lipid profile and glucose homeostasis), but also in the activation of immune cells and inflammatory mediators. Clinical trials investigating treatment with rimonabant (a selective antagonist of the cannabinoid type 1 receptor) have suggested a beneficial effect of this drug in the management of obesity. Further studies are needed to explore a possible use for rimonabant in treating type 2 diabetes and acute and chronic cardiovascular disease. Despite the slight increase in adverse events (mainly psychiatric), which has led to the recent withdrawal of rimonabant from the market, CB(1) receptor antagonism might represent a very promising therapeutic strategy to reduce the cardiovascular risk. In the present review, we focused on the most important experimental investigations into the role of the endocannabinoid system in atherosclerosis and cardiovascular risk.

Keywords
  • Animals
  • Atherosclerosis/etiology/physiopathology/prevention & control
  • Cardiovascular Diseases/etiology/physiopathology/*prevention & control
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Endocannabinoids/*metabolism
  • Humans
  • Obesity/complications/drug therapy
  • Piperidines/adverse effects/pharmacology/therapeutic use
  • Pyrazoles/adverse effects/pharmacology/therapeutic use
  • Receptor, Cannabinoid, CB1/*antagonists & inhibitors
  • Risk Factors
Citation (ISO format)
MACH, François, MONTECUCCO, Fabrizio, STEFFENS, Sabine. Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk. In: Pharmacological Reports, 2009, vol. 61, n° 1, p. 13–21.
Identifiers
ISSN of the journal1734-1140
454views
0downloads

Technical informations

Creation23/04/2012 10:26:52
First validation23/04/2012 10:26:52
Update time14/03/2023 17:23:09
Status update14/03/2023 17:23:09
Last indexation29/10/2024 19:24:26
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack